BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36607951)

  • 1. Long Noncoding RNA PSMA3 Antisense RNA 1 Promotes Cell Proliferation, Migration, and Invasion in Pancreatic Ductal Adenocarcinoma Via Targeting MicroRNA-154-5p to Positively Modulate Karyopherin Subunit Alpha 4.
    Bi J; Liang W; Wang Y; Tian W; Cao S; Liu P
    Pancreas; 2022 Sep; 51(8):1037-1046. PubMed ID: 36607951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis.
    Yun Z; Meng F; Li S; Zhang P
    Aging (Albany NY); 2021 Feb; 13(4):6041-6054. PubMed ID: 33581689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA PSMA3-AS1 promotes the progression of non-small cell lung cancer through targeting miR-17-5p/PD-L1.
    Cheng G; Li Y; Liu Z; Song X
    Adv Clin Exp Med; 2021 Oct; 30(10):1043-1050. PubMed ID: 34610219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
    Zhang M; Xu Y; Yin S; Qiu F
    Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA PSMA3-AS1 activates the progression of triple-negative breast cancer cells by blocking miR-186-5p-mediated PSME3 inhibition.
    Peng M; Yuan H
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):81-87. PubMed ID: 38279473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA CERS6-AS1 Accelerates the Proliferation and Migration of Pancreatic Cancer Cells by Sequestering MicroRNA-15a-5p and MicroRNA-6838-5p and Modulating HMGA1.
    Shen R; Wang X; Wang S; Zhu D; Li M
    Pancreas; 2021 Apr; 50(4):617-624. PubMed ID: 33939677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis.
    Xu Z; Jin H; Duan X; Liu H; Zhao X; Fan S; Wang Y; Yao T
    Environ Toxicol; 2021 Dec; 36(12):2562-2577. PubMed ID: 34520102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma.
    Cao X; Luan K; Yang J; Huang Y
    Dis Markers; 2021; 2021():3138046. PubMed ID: 34457087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA PSMA3-AS1 functions as a competing endogenous RNA to promote gastric cancer progression by regulating the miR-329-3p/ALDOA axis.
    Kan L; Yang M; Zhang H
    Biol Direct; 2023 Jul; 18(1):36. PubMed ID: 37403106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-561-5p Inhibits Cell Proliferation and Invasion by Targeting RAC1 in Pancreatic Ductal Adenocarcinoma.
    Xi B; Lai M; Zhang W; Wang F
    Ann Clin Lab Sci; 2022 Mar; 52(2):213-221. PubMed ID: 35414500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA PSMA3-AS1 enhances cell proliferation, migration and invasion by regulating miR-302a-3p/RAB22A in glioma.
    Zhou LL; Zhang M; Zhang YZ; Sun MF
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32894281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA PSMA3-AS1 promotes glioma progression through modulating the miR-411-3p/HOXA10 pathway.
    Huang T; Chen Y; Zeng Y; Xu C; Huang J; Hu W; Chen X; Fu H
    BMC Cancer; 2021 Jul; 21(1):844. PubMed ID: 34294084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA.
    Qiu BQ; Lin XH; Ye XD; Huang W; Pei X; Xiong D; Long X; Zhu SQ; Lu F; Lin K; Zhang XQ; Xu JJ; Sheng LL; Zhang XM; Zhang PF; Wu YB
    Aging (Albany NY); 2020 Jan; 12(2):1843-1856. PubMed ID: 32005028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA
    Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
    Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSMA3-AS1 induced by transcription factor PAX5 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-376a-3p to up-regulate LAMC1.
    Sun D; Li F; Liu L; Yu S; Wang H; Gao X; Liu G; Zhao Y; Qiu G; Jiang X
    Aging (Albany NY); 2022 Jan; 14(1):509-525. PubMed ID: 35022330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA PSMA3-AS1 promotes preterm delivery by inducing ferroptosis via miR-224-3p/Nrf2 axis.
    Qiu L; Lin X; Chen R; Wu Y; Yan J
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):270-278. PubMed ID: 38158666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation.
    Zhou M; Pan S; Qin T; Zhao C; Yin T; Gao Y; Liu Y; Zhang Z; Shi Y; Bai Y; Gong J; Guo X; Wang M; Qin R
    J Exp Clin Cancer Res; 2022 Sep; 41(1):288. PubMed ID: 36171592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
    Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
    J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.